Purpose: There is no consensus regarding the optimal tumor markers for melanoma. We
compared 3 tumor markers, TA90-immune complex (TA90IC), melanoma-inhibiting activity …

PURPOSE: Immune complexes (IC) containing the tumor-associated antigen TA90 can be
identified in the sera of melanoma patients. We have shown that an enzyme-linked …

Purpose Although prognosis remains poor for patients with distant metastatic melanoma, we
have observed significantly prolonged survival in patients receiving our polyvalent …

Background We hypothesized that the postoperative serum level of TA90-IC, an immune
complex of a 90-kDa tumor-associated antigen and its antibody, might have a significant …

The aim of this retrospective study was to analyse in advanced melanoma the potential
tumor markers S-100B, melanoma inhibiting activity protein (MIA) and YKL-40 compared to …

BACKGROUND: Standard prognostic factors, including precise staging of the regional
lymph nodes, cannot accurately determine which early-stage melanomas will metastasize …

BACKGROUND TA‐90 is a tumor‐associated antigen first identified in the urine and sera of
patients with metastatic melanoma. In the early stages of disease, TA‐90 is present in …

It has recently been shown that the serum level of melanoma-inhibitory protein (MIA)
provides useful information for the therapy and follow-up of patients with malignant …

Melanoma-associated antigens are at the center of many immunotherapeutic trials in
melanoma. Little is known about the impact of antigen expression on the natural course of …

Background: In patients with melanoma, early dissemination via lymphatic and
hematogenous routes is frequently seen. Thus, besides clinical follow-up examination and …